Spatial Multi-omics Grant Program – Pennsylvania

Deadline:
Open to residents of the Americas

Elevate your spatial biology research with GeoMx® & CosMx™

University of Pennsylvania, Children’s Hospital of Pennsylvania, and Wistar Institute researchers are invited to take the leap into spatial transcriptomics and apply for this exclusive grant program. One winner will be awarded a 2-slide project utilizing either the CosMx 1k Universal Cell Characterization RNA Panel, the CosMx Human 6k Discovery Panel, OR GeoMx RNA Panel.

Learn more about the panels:

The CosMx Universal Cell Characterization Panel is a fully-validated RNA assay for the CosMx Spatial Molecular Imager that provides robust tissue mapping, cell typing, and analysis of cell states and interactions on a wide range of tissues and solid tumors.

  • Provides robust tissue mapping, cell typing, and analysis of cell states and interactions on a wide range of tissue and organs.
  • Reveals interactions between cells including ligand-receptor interactions, interferon response, and signaling pathways such as MAPK, NF-kB, Wnt, and Shh
  • Profile states of metabolism, circadian rhythm, antigen presentation, damage, activation, checkpoints, inflammation, proliferation, secretion, stress-response, wound healing, and much more.

The CosMx Human 6k Discovery Panel enables researchers to accelerate their single cell spatial transcriptomics with this fully validated, 6K plex RNA panel, with simple sample preparation, an easy-to-use and reliable spatial multiomics platform and streamlined data analysis.

Circular 'wheel' logo for CosMx 6K Human Discovery Panel
  • Measure over 6,000 RNA targets plus protein markers for cell segmentation
  • Customize with up to 200 additional RNA targets
  • Pofile the most significant genes across every biological pathway
  • Best-in-class cell segmentation algorithms for accurate spatial single cell analysis

GeoMx RNA assays allow you to profile the whole transcriptome from a single FFPE or fresh frozen slide with Digital Spatial Profiling. GeoMx Assays are pre-validated and modular to provide flexibility and support a range of research needs. Available content covers immunology, immuno-oncology, neurodegeneration, and neuroinflammation with a rapidly growing pipeline.

Award Details

  • 2-Slide CosMx 1k Universal Cell Characterization Panel, CosMx Human 6K Discovery Panel, or GeoMx RNA Panel Project – Project will be run at the NanoString Customer Experience Lab, Seattle, WA
  • Required reagents for the project
  • Project planning and data analysis consultation

Application Form

Application deadline: June 3, 2024

Terms & Conditions

Publication of Project Results:

Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and each winner: webinar, case study, blog post, or poster presentation. Each winner and runner up agrees that NanoString shall have the right to publicly announce the winner’s & runner up’s name and research topic and use anonymized data from the winner’s & runner up’s project in application notes including in marketing materials and seminars.

Eligibility and Requirements:

Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research. The winner must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program. Grant winners must meet with their Field Application Scientist to review their project in detail. The project will be run at NanoString’s Customer Experience Lab, Headquarters in Seattle, WA.

Miscellaneous:

By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All grant applicants agree that NanoString may process the personal data he or she provides as part of application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at nanostring.com/privacy. The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded grant is allowed, except as otherwise permitted by NanoString. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.